The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Pierluigi Porcu Ming J Poi Mitch A Phelps Kristie A Blum Robert A Baiocchi Jeffrey A Jones Kami Maddocks John C. Byrd |
| Publication date | April 7, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |